India
· Delayed Price · Currency is INR Gland Pharma Company Description
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.
The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services.
The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
| Country | India |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,217 |
| CEO | Srinivas Sadu |
Contact Details
Address: Plot No. 11 & 84, TSIIC Phase: IV Hyderabad, 502307 India | |
| Phone | 91 84 5569 9999 |
| Website | glandpharma.com |
Stock Details
| Ticker Symbol | GLAND |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE068V01023 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Srinivas Sadu | Chief Executive Officer and Executive Chairman |
| Ravi Shekhar Mitra | Chief Financial Officer |
| Sampath Kumar Pallerlamudi | Company Secretary and Vice-President of Compliance & CSR |
| Satnam Singh Loomba | Chief Operating Officer |
| Ankit Gupta | Head of Investments, Strategy and Investor Relations |
| Surinder Koul | Head of Domestic Marketing |
| K Raghuramachandra Rao | Head of Quality |
| R.V.R. Prabhakara Sastry | Senior Vice President of Research & Development |
| Rong Wu | Chief Financial Controller |